Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 06 2021
Historique:
received: 26 10 2020
accepted: 21 04 2021
entrez: 15 6 2021
pubmed: 16 6 2021
medline: 3 11 2021
Statut: epublish

Résumé

The family of RNA-binding proteins (RBP) functions as a crucial regulator of multiple biological processes and diseases. However, RBP function in the clinical setting of idiopathic pulmonary fibrosis (IPF) is still unknown. We developed a practical in silico screening approach for the characterization of RBPs using multi-sources data information and comparative molecular network bioinformatics followed by wet-lab validation studies. Data mining of bulk RNA-Sequencing data of tissues of patients with IPF identified Quaking (QKI) as a significant downregulated RBP. Cell-type specific expression was confirmed by single-cell RNA-Sequencing analysis of IPF patient data. We systematically analyzed the molecular interaction network around QKI and its functional interplay with microRNAs (miRs) in human lung fibroblasts and discovered a novel regulatory miR-506-QKI axis contributing to the pathogenesis of IPF. The in silico results were validated by in-house experiments applying model systems of miR and lung biology. This study supports an understanding of the intrinsic molecular mechanisms of IPF regulated by the miR-506-QKI axis. Initially applied to human lung disease, the herein presented integrative in silico data mining approach can be adapted to other disease entities, underlining its practical relevance in RBP research.

Identifiants

pubmed: 34127686
doi: 10.1038/s41598-021-89531-7
pii: 10.1038/s41598-021-89531-7
pmc: PMC8203802
doi:

Substances chimiques

MIRN506 microRNA, human 0
MicroRNAs 0
QKI protein, human 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12456

Références

F1000Res. 2018 Jun 14;7:
pubmed: 31489175
Circulation. 2019 Sep 10;140(11):937-951
pubmed: 31284728
Genes Dev. 2017 Sep 15;31(18):1894-1909
pubmed: 29021242
Front Physiol. 2020 May 25;11:520
pubmed: 32523550
Eur Respir J. 2015 Oct;46(4):1113-30
pubmed: 26424523
J Proteome Res. 2019 Feb 1;18(2):623-632
pubmed: 30450911
Genome Biol. 2014;15(12):550
pubmed: 25516281
Circulation. 2011 Aug 9;124(6):720-30
pubmed: 21788589
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
N Engl J Med. 2018 May 10;378(19):1811-1823
pubmed: 29742380
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
Int J Mol Sci. 2020 Jul 02;21(13):
pubmed: 32630753
Nat Commun. 2020 Jan 31;11(1):633
pubmed: 32005803
Nature. 2008 Sep 4;455(7209):58-63
pubmed: 18668040
Nat Commun. 2017 Feb 23;8:14532
pubmed: 28230051
Eur Heart J. 2020 Aug 14;41(31):2983-2996
pubmed: 31898722
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Aging (Albany NY). 2019 Mar 28;11(6):1821-1831
pubmed: 30923258
Nature. 2008 Sep 4;455(7209):64-71
pubmed: 18668037
EMBO J. 2018 Jul 2;37(13):
pubmed: 29871889
Methods. 2015 Mar;74:83-9
pubmed: 25484339
Nature. 2020 Jul;583(7818):711-719
pubmed: 32728246
Bioinformatics. 2008 Jan 15;24(2):282-4
pubmed: 18006545
Thorax. 2015 Jan;70(1):48-56
pubmed: 25217476
Eur Heart J. 2021 Jan 7;42(2):178-188
pubmed: 33245749
Int J Mol Sci. 2020 Jun 09;21(11):
pubmed: 32527064
EMBO Rep. 2020 Jan 7;21(1):e49024
pubmed: 31808593
Circ Res. 2018 Jan 19;122(2):246-254
pubmed: 29133306
Lancet. 2017 May 13;389(10082):1941-1952
pubmed: 28365056
Sci Adv. 2020 Jul 08;6(28):eaba1983
pubmed: 32832599
Respir Res. 2019 Jan 21;20(1):16
pubmed: 30665416
Nat Rev Mol Cell Biol. 2018 May;19(5):327-341
pubmed: 29339797
Nat Methods. 2012 Apr;9(4):345-50
pubmed: 22453911
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Stevan D Stojanović (SD)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.

Maximilian Fuchs (M)

Chair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, Erlangen, Germany.

Chunguang Liang (C)

Chair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, Erlangen, Germany.

Kevin Schmidt (K)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.

Ke Xiao (K)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.
Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM), Hannover, Germany.

Annette Just (A)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.

Angelika Pfanne (A)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.

Andreas Pich (A)

Institute of Toxicology and Core Unit Proteomics, Hannover Medical School, Hannover, Germany.

Gregor Warnecke (G)

Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany.

Peter Braubach (P)

Institute of Pathology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Christina Petzold (C)

Institute of Pathology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Danny Jonigk (D)

Institute of Pathology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

Jörg H W Distler (JHW)

Department of Internal Medicine 3-Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, Erlangen, Germany.

Jan Fiedler (J)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany. Fiedler.Jan@mh-hannover.de.
Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM), Hannover, Germany. Fiedler.Jan@mh-hannover.de.
Fraunhofer Cluster of Excellence for Immune Mediated Diseases, Hannover, Germany. Fiedler.Jan@mh-hannover.de.

Thomas Thum (T)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany. Thum.Thomas@mh-hannover.de.
Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM), Hannover, Germany. Thum.Thomas@mh-hannover.de.
Fraunhofer Cluster of Excellence for Immune Mediated Diseases, Hannover, Germany. Thum.Thomas@mh-hannover.de.
REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany. Thum.Thomas@mh-hannover.de.

Meik Kunz (M)

Chair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, Erlangen, Germany. meik.kunz@fau.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH